These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Increase in prevalence of leprosy caused by dapsone-resistant Mycobacterium leprae. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1982 Jan; 30(52):637-8. PubMed ID: 6798411 [No Abstract] [Full Text] [Related]
3. Six cases of dapsone-resistant tuberculoid leprosy. Pearson JM; Kiran KU; Stanley JN Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):534-5. PubMed ID: 6399070 [No Abstract] [Full Text] [Related]
4. Co-incident (simultaneous) dapsone sensitive and dapsone resistant leprosy. McDougall AC; Ross WF Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):214-5. PubMed ID: 6749709 [No Abstract] [Full Text] [Related]
5. Survey of primary dapsone-resistant leprosy. Wang HY; Li WZ; Yang LH; Huang HS; Lu WQ; Yu LC Proc Chin Acad Med Sci Peking Union Med Coll; 1986; 1(3):173-5. PubMed ID: 3321049 [No Abstract] [Full Text] [Related]
6. [Prevalence of dapsone-resistant leprosy in Burundi. Temporary results]. Bourland J; Van Loo L; Pattyn SR Acta Leprol; 1982; (86-87):29-33. PubMed ID: 6815995 [No Abstract] [Full Text] [Related]
7. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance. Waters MF; Pearson JM; Rees RJ Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850 [No Abstract] [Full Text] [Related]
8. The problem of dapsone-resistant leprosy. Pearson JM Int J Lepr Other Mycobact Dis; 1981 Dec; 49(4):417-20. PubMed ID: 7042605 [No Abstract] [Full Text] [Related]
9. Primary dapsone-resistant leprosy in San Francisco. Gelber RH Int J Lepr Other Mycobact Dis; 1984 Dec; 52(4):471-4. PubMed ID: 6399067 [TBL] [Abstract][Full Text] [Related]
14. The clinical diagnosis of dapsone resistant leprosy. Taylor PM Lepr India; 1982 Jan; 54(1):117-22. PubMed ID: 7047897 [TBL] [Abstract][Full Text] [Related]
15. Combined clofazimine- and dapsone-resistant leprosy. A case report. Kar HK; Bhatia VN; Harikrishnan S Int J Lepr Other Mycobact Dis; 1986 Sep; 54(3):389-91. PubMed ID: 3528345 [TBL] [Abstract][Full Text] [Related]
16. [Advances in the chemotherapy of leprosy]. Grosset J Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002 [TBL] [Abstract][Full Text] [Related]
17. Infectivity of secondary dapsone-resistant cases. Jesudasan K; Pannikar V; Christian M Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):418-21. PubMed ID: 3047282 [TBL] [Abstract][Full Text] [Related]
18. Mycobacterium leprae persisters after treatment with dapsone and rifampicin. Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851 [No Abstract] [Full Text] [Related]
19. [2 cases of paucibacillary leprosy resistant to dapsone]. Janssens L Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986 [TBL] [Abstract][Full Text] [Related]
20. The sensitivity to Dapsone (DDS) of Mycobacterium leprae from patients with and without previous treatment. Shepard CC; Levy L; Fasal P Am J Trop Med Hyg; 1969 Mar; 18(2):258-63. PubMed ID: 4888029 [No Abstract] [Full Text] [Related] [Next] [New Search]